Long term (current) use of immunosuppressive biologic
Billable / specificPOA exempt
Z79.620 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.
Inclusion terms
Applicable to
- Long term (current) use of adalimumab
- Long term (current) use of etanercept
- Long term (current) use of infliximab
- Long term (current) use of monoclonal antibodies
Includes (from Z79)
- long term (current) drug use for prophylactic purposes
- Note: Z codes represent reasons for encounters. A corresponding procedure code must accompany a Z code if a procedure is performed. Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00-Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:
- Note: (a) When a person who may or may not be sick encounters the health services for some specific purpose, such as to receive limited care or service for a current condition, to donate an organ or tissue, to receive prophylactic vaccination (immunization), or to discuss a problem which is in itself not a disease or injury.
- Note: (b) When some circumstance or problem is present which influences the person's health status but is not in itself a current illness or injury.
Excludes2
Not included here — may be reported together when both conditions exist.
Code also
An additional code may be needed.
Also known as
- Long term (current) use of adalimumab
- Long term (current) use of etanercept
- Long term (current) use of infliximab
- Long term (current) use of monoclonal antibodies
- Long-term, adalimumab
- Long-term, etanercept
- Long-term, immunosuppressive biologic
- Long-term, infliximab
- Long-term, monoclonal antibodies
Parent code
- Z79.62Long term (current) use of immunosuppressantHeader